Mechanisms of the proteinuria induced by Rho GTPases

Kidney International

Volumn 81, Issue 11, 2012, Pages 1075-1085

  Wang, Liming ^a   Ellis, Mathew J ^a   Gomez, Jose A ^a   Eisner, William ^a   Fennell, Walter ^b   Howell, David N ^b   Ruiz, Phillip ^c   Fields, Timothy A ^d   Spurney, Robert F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

cell signaling; glomerular disease; podocyte

Indexed keywords

ACTIN; MESSENGER RNA; NEPHRIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SYNAPTOPODIN;

ACTIN POLYMERIZATION; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL ASSAY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; GLOMERULUS FILTRATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; REVIEW; STRESS FIBER; TRANSGENE; TRANSGENIC MOUSE;

EID: 84862777971     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.472     Document Type: Article

References (54)

1. Somlo S, Mundel P. Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335. (Pubitemid 30187426)
2. Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108: 1583-1587. (Pubitemid 33144868)
3. Pavenstadt H. Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol 2000; 278: F173-F179. (Pubitemid 30131271)
4. Yanagida-Asanuma E, Asanuma K, Kim K et al. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol 2007; 171: 415-427. (Pubitemid 47344675)
5. Asanuma K, Yanagida-Asanuma E, Faul C et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006; 8: 485-491.
6. Lu TC, He JC, Wang ZH et al. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem 2008; 283: 8173-8182.
7. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348(Part 2): 241-255. (Pubitemid 30345195)
8. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996; 12: 463-518.
9. Schwartz M. Rho signalling at a glance. J Cell Sci 2004; 117: 5457-5458. (Pubitemid 40012192)
10. Seasholtz TM, Brown JH. RHO SIGNALING in vascular diseases. Mol Interv 2004; 4: 348-357. (Pubitemid 40124382)
11. Kanda T, Wakino S, Hayashi K et al. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003; 64: 2009-2019. (Pubitemid 37449535)
12. Nagatoya K, Moriyama T, Kawada N et al. Y-27632 prevent tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61: 1684-1695. (Pubitemid 34437922)
13. Nishikimi T, Matsuoka H. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. J Pharmacol Sci 2006; 100: 22-28. (Pubitemid 43161610)
14. Satoh S, Yamaguchi T, Hitomi A et al. Fasudil attenuates interstitialfibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 2002; 455: 169-174. (Pubitemid 35351611)
15. Sun GP, Kohno M, Guo P et al. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006; 17: 2193-2201. (Pubitemid 44141909)
16. Shibata S, Nagase M, Fujita T. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol 2006; 17: 754-764.
17. Sakurai N, Kuroiwa T, Ikeuchi H et al. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy. Nephrol Dial Transplant 2009; 24: 2378-2383.
18. Hidaka T, Suzuki Y, Yamashita M et al. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration. Am J Pathol 2008; 172: 603-614. (Pubitemid 351354534)
19. Koshikawa S, Nishikimi T, Inaba C et al. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats. J Hypertens 2008; 26: 1837-1848.
20. Zhu L, Jiang R, Aoudjit L et al. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. J Am Soc Nephrol 2011; 22: 1621-1630.
21. Gingrich JR, Roder J. Inducible gene expression in the nervous system of transgenic mice. Annu Rev Neurosci 1998; 21: 377-405. (Pubitemid 28150668)
22. Shigehara T, Zaragoza C, Kitiyakara C et al. Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 2003; 14: 1998-2003. (Pubitemid 36909907)
23. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods 2001; 24: 247-256. (Pubitemid 32846431)
24. Mundel P, Heid HW, Mundel TM et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 1997; 139: 193-204. (Pubitemid 27444091)
25. Shi J, Wei L. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz) 2007; 55: 61-75. (Pubitemid 46559196)
26. Zhu J, Sun N, Aoudjit L et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 2008; 73: 556-566. (Pubitemid 351264104)
27. Huber TB, Hartleben B, Kim J et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23: 4917-4928. (Pubitemid 36793337)
28. Li Z, Dong X, Wang Z et al. Regulation of PTEN by Rho small GTPases. Nat Cell Biol 2005; 7: 399-404. (Pubitemid 40533130)
29. Kestila M, Lenkkeri U, Mannikko M et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582. (Pubitemid 128374693)
30. Putaala H, Soininen R, Kilpelainen P et al. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001; 10: 1-8. (Pubitemid 32051561)
31. Rantanen M, Palmen T, Patari A et al. Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 2002; 13: 1586-1594. (Pubitemid 34579248)
32. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214. (Pubitemid 46884251)
33. Aaltonen P, Luimula P, Astrom E et al. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 2001; 81: 1185-1190. (Pubitemid 32911967)
34. Benigni A, Tomasoni S, Gagliardini E et al. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001; 12: 941-948. (Pubitemid 32378334)
35. Kawachi H, Koike H, Kurihara H et al. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 2000; 57: 1949-1961. (Pubitemid 30252286)
36. Luimula P, Ahola H, Wang SX et al. Nephrin in experimental glomerular disease. Kidney Int 2000; 58: 1461-1468.
37. Wang L, Fields TA, Pazmino K et al. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. J Am Soc Nephrol 2005; 16: 3611-3622. (Pubitemid 46211282)
38. Wang L, Ellis MJ, Fields TA et al. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press Res 2008; 31: 111-121. (Pubitemid 351630068)
39. Yuan H, Takeuchi E, Taylor GA et al. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002; 13: 946-956. (Pubitemid 34274091)
40. Barisoni L, Kriz W, Mundel P et al. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51-61. (Pubitemid 29034942)
41. Chuang PY, He JC. Signaling in regulation of podocyte phenotypes. Nephron Physiol 2009; 111: p9-p15.
42. Verma R, Kovari I, Soofi A et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116: 1346-1359.
43. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147. (Pubitemid 43882099)
44. Srivastava T, Garola RE, Whiting JM et al. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001; 59: 118-125. (Pubitemid 32055220)
45. Susztak K, Raff AC, Schiffer M et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233. (Pubitemid 43343319)
46. Verzola D, Gandolfo MT, Ferrario F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272. (Pubitemid 350059668)
47. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-1634. (Pubitemid 40770751)
48. Wang HR, Zhang Y, Ozdamar B et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003; 302: 1775-1779. (Pubitemid 37505743)
49. Chellaiah MA, Soga N, Swanson S et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000; 275: 11993-12002. (Pubitemid 30237772)
50. Wang L, Flannery PJ, Rosenberg PB et al. Gq-dependent signaling upregulates COX2 in glomerular podocytes. J Am Soc Nephrol 2008; 19: 2108-2118.
51. Wang L, Chang JH, Paik SY et al. Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol Endocrinol 2011; 25: 1376-1386.
52. Spurney RF. Role of C-terminal serines in desensitization and phosphorylation of the mouse thromboxane receptor. J Biol Chem 1998; 273: 28496-28503. (Pubitemid 28496156)
53. Wang L, Gesty-Palmer D, Fields TA et al. Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2). Wang L, Gesty-Palmer D, Fields T Mol Endocrinol 2009; 23: 1455-1465.
54. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9. (Pubitemid 10046307)